Aurobindo Pharma consolidated net profit rises 7.62% in the December 2025 quarter
(14 Feb 2026)

Back
Net profit of Aurobindo Pharma rose 7.62% to Rs 910.29 crore in the quarter ended December 2025 as against Rs 845.81 crore during the previous quarter ended December 2024. Sales rose 9.01% to Rs 8604.51 crore in the quarter ended December 2025 as against Rs 7893.15 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales8604.517893.15 9
OPM %20.6119.99 -
PBDT1868.581618.38 15
PBT1403.851199.85 17
NP910.29845.81 8

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew